Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 21, 2020
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trialJosep Gomez-Lara, Luis Ortega-Paz, Salvatore Brugaletta, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 21, 2017
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trialGiosafat Spitaleri, Elisabetta Moscarella, Salvatore Brugaletta, et al.
The International Journal of Cardiovascular Imaging|November 24, 2011
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffoldSalvatore Brugaletta, Josep Gomez-Lara, Hector M Garcia-Garcia, et al.
The International Journal of Cardiovascular Imaging|October 14, 2010
Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffoldSalvatore Brugaletta, Hector M Garcia-Garcia, Scot Garg, et al.
JACC. Cardiovascular Interventions|January 25, 2015
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction)Salvatore Brugaletta, Tommaso Gori, Adrian F Low, et al.
JACC. Cardiovascular Interventions|December 24, 2011
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomographyJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
International Journal of Cardiology|April 13, 2013
Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION trialSalvatore Brugaletta, Manel Sabate, Victoria Martin-Yuste, et al.
The American Journal of Cardiology|March 17, 2018
Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial)Giosafat Spitaleri, Salvatore Brugaletta, Giancarla Scalone, et al.
JACC. Cardiovascular Interventions|September 24, 2011
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomographyJosep Gomez-Lara, Maria Radu, Salvatore Brugaletta, et al.
JACC. Cardiovascular Interventions|February 18, 2014
Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography studyChristos V Bourantas, Michail I Papafaklis, Anna Kotsia, et al.
Pageof 8